As head of VUB's Molecular Imaging group and UZ Brussel's nuclear medicine department, he spun out Precirix to turn camelid antibody research into precision radiopharmaceuticals.
Studied at
Vrije Universiteit Brussel
Before
Professor of Nuclear Medicine at Vrije Universiteit Brussel (MIMA group)